-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation